Rchr

J-GLOBAL ID：201801014632565517 Update date: Oct. 03, 2023

Yuko Makita

Yuko Makita

Papers (12)：

Hitoshi Suzuki, Junichi Yasutake, Yuko Makita, Yuki Tanbo, Kohei Yamasaki, Tadashi Sofue, Toshiki Kano, Yusuke Suzuki. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney international. 2018. 93. 3. 700-705
Reo Kanda, Hiroaki Io, Junichiro Nakata, Yuko Makita, Yu Sasaki, Mayumi Matsumoto, Keiichi Wakabayashi, Yasuhiko Tomino, Yusuke Suzuki. Evaluation of Long-Term Combination Therapy With Peritoneal Dialysis and Hemodialysis. THERAPEUTIC APHERESIS AND DIALYSIS. 2017. 21. 2. 180-184
Akiko Takahata, Kento Kitada, Chieko Nogi, Satoko Arai, Yuko Makita, Hitoshi Suzuki, Junichiro Nakata, Satoshi Horikoshi, Toru Miyazaki, Yusuke Suzuki. AIM(CD5L) REGULATES GLOMERULAR IGA DEPOSITION AND ITS PHLOGOGENISITY IN IGA NEPHROPATHYREGULATES THE GLOMERULAR IGA DEPOSITION AND ITS PHLOGOGENISITY IN IGA NEPHROPATHY. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016. 31. 101-102
Hitoshi Suzuki, Yuko Makita, Miyuki Takagi, Toshiki Kano, Chieko Nogi, Akiko Takahata, Yusuke Suzuki. GLOMERULAR GALACTOSE-DEFICIENT IGA1 IS SPECIFIC FOR IGA NEPHROPATHY. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016. 31. 127-128
Junichiro Nakata, Hiroaki Io, Tomonari Watanabe, Yu Sasaki, Yuko Makita, Tatsuya Aoki, Hiroyuki Yanagawa, Reo Kanda, Yasuhiko Tomino. Impact of preoperative ultrasonography findings on the patency rate of vascular access in Japanese hemodialysis patients. SPRINGERPLUS. 2016. 5

ｍore...

MISC (24)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM